1. Pink Sheet

When It Comes To A COVID-19 Vaccine For Kids, It Will Be Awhile

 
• By Jessica Merrill

US FDA will be cautious about development of a COVID-19 vaccine for children, Commissioner Hahn says at the Financial Times US Pharma And Biotech Summit.

Group of kindergarten kids friends arm around sitting and smiling fun
Health officials are beginning to contemplate how to handle a COVID vaccine for children • Source: Shutterstock

As public attention is focused on when the first vaccines for COVID-19 may reach the market, the industry and regulators are beginning to think about the steps that will need to be taken to expand the use of those vaccines to children. US Food and Drug Administration Commissioner Stephen Hahn suggested the agency will take a cautious approach to moving the products into the younger population.

None of the large Phase III clinical trials for the investigational COVID-19 vaccines currently in development by Pfizer Inc.,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

More from Pink Sheet

US FDA Could Seek Stronger Warnings On SSRI Antidepressant Risks During Pregnancy

 
• By Sue Sutter

Testimony during a July 21 ‘expert panel’ could help justify stronger warnings across the class about potential adverse effects on mother and baby. Panelists ranged from clinicians who said depression during pregnancy should be treated, to those who said sadness has been “medicalized."

World’s First Hemato-Oncology Microbiota Therapeutic Among Latest New EU Filings

 
• By Neena Brizmohun

The European Medicines Agency has started reviewing for potential EU marketing approval six new products, including MaaT Pharma’s microbiota therapeutic for acute-graft-versus-host disease, and AstraZeneca's camizestrant for locally advanced or metastatic breast cancer.

Sponsors Asked, EMA Delivered: One Handbook To Navigate CTIS

 
• By Vibha Sharma

The European Medicines Agency has revised the sponsor handbook for the Clinical Trials Information System, bringing together guidance that was previously scattered across multiple platforms and documents to help sponsors navigate the trial process more efficiently.